Gene · 4485
Papers4,329
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 4,329
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FUNDC1: A Promising Mitophagy Regulator at the Mitochondria-Associated Membrane for Cardiovascular Diseases. | Front Cell Dev Biol | 2021 | 35096821 | PubTator, text mining | PubMed |
| Chrysin Modulates Aberrant Epigenetic Variations and Hampers Migratory Behavior of Human Cervical (HeLa) Cells. | Front Genet | 2021 | 35096000 | PubTator, text mining | PubMed |
| Natural Killer Cells in the Malignant Niche of Multiple Myeloma. | Front Immunol | 2021 | 35087536 | PubTator, text mining | PubMed |
| Crosstalk Among YAP, LncRNA, and Tumor-Associated Macrophages in Tumorigenesis Development. | Front Oncol | 2021 | 35071016 | PubTator, text mining | PubMed |
| Characterization With KRAS Mutant Is a Critical Determinant in Immunotherapy and Other Multiple Therapies for Non-Small Cell Lung Cancer. | Front Oncol | 2021 | 35070984 | PubTator, text mining | PubMed |
| The Regulation of Growth in Developing, Homeostatic, and Regenerating Tetrapod Limbs: A Minireview. | Front Cell Dev Biol | 2021 | 35047496 | PubTator, text mining | PubMed |
| The Role of Altered Mitochondrial Metabolism in Thyroid Cancer Development and Mitochondria-Targeted Thyroid Cancer Treatment. | Int J Mol Sci | 2021 | 35008887 | PubTator, text mining | PubMed |
| The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises. | Int J Mol Sci | 2021 | 35008857 | PubTator, text mining | PubMed |
| Inflammation, Oxidative Stress, Senescence in Atherosclerosis: Thioredoxine-1 as an Emerging Therapeutic Target. | Int J Mol Sci | 2021 | 35008500 | PubTator, text mining | PubMed |
| The Diagnostic and Prognostic Value of Plasma Galectin 3 in HFrEF Related to the Etiology of Heart Failure. | Front Cardiovasc Med | 2021 | 35004876 | PubTator, text mining | PubMed |
| Novel Insights Into the Pathogenesis of Diabetic Cardiomyopathy and Pharmacological Strategies. | Front Cardiovasc Med | 2021 | 35004869 | PubTator, text mining | PubMed |
| Biological Pathways Associated With the Development of Pulmonary Toxicities in Mesothelioma Patients Treated With Radical Hemithoracic Radiation Therapy: A Preliminary Study. | Front Oncol | 2021 | 35004305 | PubTator, text mining | PubMed |
| Tumor-Associated Macrophages: Critical Players in Drug Resistance of Breast Cancer. | Front Immunol | 2021 | 34992609 | PubTator, text mining | PubMed |
| FOXO1 Is a Critical Switch Molecule for Autophagy and Apoptosis of Sow Endometrial Epithelial Cells Caused by Oxidative Stress. | Oxid Med Cell Longev | 2021 | 34970413 | PubTator, text mining | PubMed |
| MST1 mediates the N-methyl-D-aspartate-induced excitotoxicity in mouse cortical neurons. | Cell Mol Life Sci | 2021 | 34967918 | PubTator, text mining | PubMed |
| The Molecular Roles and Clinical Implications of Non-Coding RNAs in Gastric Cancer. | Front Cell Dev Biol | 2021 | 34966746 | PubTator, text mining | PubMed |
| MiR-429 Inhibits the Angiogenesis of Human Brain Microvascular Endothelial Cells through SNAI2-Mediated GSK-3β/β-Catenin Pathway. | Comput Math Methods Med | 2021 | 34966442 | PubTator, text mining | PubMed |
| Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update and Prospective. | Pharmaceutics | 2021 | 34959397 | PubTator, text mining | PubMed |
| The Extracellular Matrix in Soft Tissue Sarcomas: Pathobiology and Cellular Signalling. | Front Cell Dev Biol | 2021 | 34957097 | PubTator, text mining | PubMed |
| Monitoring Spontaneous Quiescence and Asynchronous Proliferation-Quiescence Decisions in Prostate Cancer Cells. | Front Cell Dev Biol | 2021 | 34957090 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4485/papers?page=58